Financials
Financial year 2026
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 28.6 million
▲ 15% vs 2025
Profit
Healthy€ 370,209
▼ 55% vs 2025
Debts
High€ 11.3 million
▲ 2% vs 2025
M.D.D. PHARMA from Wavre, company number BE0437759119, closed financial year 2026 with a result of € 370,209 after tax. For that financial year M.D.D. PHARMA recorded revenue of € 28.6 million and equity of € 565,871. Compared with financial year 2025, the result moved from € 823,861 to € 370,209. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
What happened at M.D.D. PHARMA?
What happened at M.D.D. PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 370,209 (▼ 55% vs 2025). Source: NBB ↗
- Philippe Lacroix stepped down as director. NBB
- Eveline Maryns stepped down as director. NBB
- Arnaud Berken stepped down as director. NBB
- Philippe Lacroix became a director. NBB
- Eveline Maryns became a director. NBB
- Arnaud Berken became a director. NBB
- New establishment in Kortrijk. KBO
In short
From € 709,334 profit in 2024 to € 370,209 profit in 2026.
Paid € 966,194 in corporate taxes since 2024.
Best year ever: 2025, with € 823,861 profit.
Paid out € 1.9 million in dividends to the owners in total.
A new publication or filing at M.D.D. PHARMA? We notify you, reason included.
Follow M.D.D. PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2026 annual accounts
Philippe Lacroix
Director
since 2023 · until 2026
Eveline Maryns
Director
since 2023 · until 2026
Arnaud Berken
Director
since 2023 · until 2026
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue Pasteur 2
1300 Wavre
Zwevegemsestraat(Kor) 38
8500 Kortrijk
Active since 27 September 1989
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 23 companies are registered at this address.
VAQUAFERRA
€ -58,200 gross margin · 2021
BENU same network
€ 172.2 million revenue · 2026
CENTRE RX DE WAVRE
€ 557,316 gross margin · 2025
IMMO X
€ 119,688 gross margin · 2025
BENU Management
€ 9.5 million revenue · 2026
+18 more
Details
- Company number
- 0437.759.119
- VAT number
- BE 0437.759.119
- Registered office
- Avenue Pasteur 2, 1300 Wavre
- Names & denominations
- M.D.D. PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 6 July 1989
- Peppol
- Active · Active since 10 Jun 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers